← Leaderboards
Lee E Goldstein
Brigham And Women'S Hospital
$17,632,006
Attributed
$31,719,697
Total exposure
24
Grants
16
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $7.4M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$32,142,550 · 25
By mechanism
U01$8,909,544 · 2
RF1$6,977,847 · 3
R01$5,017,221 · 4
S10$2,163,016 · 5
R61$1,959,854 · 1
R33$1,766,629 · 1
Top collaborators
- Oliver Fiehn5 shared
- Rima F Kaddurah-Daouk5 shared
- Monica Lizet Moya5 shared
- David Wishart5 shared
- Rhoda Au4 shared
- Michael Alosco3 shared
- Gareth R Howell3 shared
- Jesse Benjamin Mez3 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Mel B Feany$26,965,920
- Richard L Stevens$8,274,576
- Dennis J Selkoe$33,298,694
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposS DiseaseBrainFundingBloodBiological MarkersPhenotypePathologyPre-ClinicalCohortDementiaTau ProteinsParticipantUniversitiesBostonSpecimenResearch PersonnelResourcesAmyloid Beta-ProteinS Disease Related DementiaLinkMapsNeurodegenerative DisordersMolecular
Grant awards (55)
The Role of Chemical Exposures in Alzheimer's Disease (AD) and its Trajectory$2,107,225
U01 · FY2025 · AG
Leveraging novel mouse models to investigate toxic metal exposures on brain aging and Alzheimer's disease$2,018,294
U01 · FY2025 · AG · contact PI
Validation of Lens Beta-Amyloid as a Novel Biomarker for Early Detection of Alzheimer's Disease at the Boston University Alzheimer's Disease Research$782,114
R01 · FY2025 · AG · contact PI
Lasting Impacts: Dynamic, Fully Natural Bioprinted 3D Human Neurovascular Biomimetic Model to Study Traumatic Brain Injury Pathophysiology$588,081
R33 · FY2025 · HL
Precision Brain Health Monitoring for Alzheimer's Disease Risk Detection in the Framingham Study$569,405
R01 · FY2025 · AG
Lens β-Amyloid Biomarker for Early Detection of Preclinical Alzheimer's Disease in the Framingham Study$546,892
R01 · FY2025 · AG · contact PI
Core F: Biomarker Core$331,289
P30 · FY2025 · AG · contact PI
Laser Ablation System for Ultrafast Elemental Mapping of Clinical and Preclinical Biospecimens$316,012
S10 · FY2025 · OD · contact PI
The Role of Chemical Exposures in Alzheimer's Disease (AD) and its Trajectory$79,380
U01 · FY2025 · AG
The Role of Chemical Exposures in Alzheimer's Disease (AD) and its Trajectory$55,842
U01 · FY2025 · AG
The Role of Chemical Exposures in Alzheimer's Disease (AD) and its Trajectory$26,460
U01 · FY2025 · AG
The Role of Chemical Exposures in Alzheimer's Disease (AD) and its Trajectory$2,499,382
U01 · FY2024 · AG
Leveraging novel mouse models to investigate toxic metal exposures on brain aging and Alzheimer's disease$2,122,961
U01 · FY2024 · AG · contact PI
Validation of Lens Beta-Amyloid as a Novel Biomarker for Early Detection of Alzheimer's Disease at the Boston University Alzheimer's Disease Research$811,737
R01 · FY2024 · AG · contact PI
ICP-TOF Mass Spectrometer for Ultrafast Elemental Mapping of Clinical and Preclinical Biospecimens$582,750
S10 · FY2024 · OD · contact PI
Lasting Impacts: Dynamic, Fully Natural Bioprinted 3D Human Neurovascular Biomimetic Model to Study Traumatic Brain Injury Pathophysiology$570,371
R33 · FY2024 · HL
Core F: Biomarker Core$331,289
P30 · FY2024 · AG · contact PI
Validation of Lens Beta-Amyloid as a Novel Biomarker for Early Detection of Alzheimer's Disease at the Boston University Alzheimer's Disease Research$824,998
R01 · FY2023 · AG · contact PI
Impact of Toxic Metal Exposures in Novel Genetic Mouse Models of Late-Onset Alzheimer's Disease$822,643
R56 · FY2023 · AG · contact PI
Lasting Impacts: Dynamic, Fully Natural Bioprinted 3D Human Neurovascular Biomimetic Model to Study Traumatic Brain Injury Pathophysiology$608,177
R33 · FY2023 · HL
TBI Identification and Monitoring Through Retinal Scanning$517,500
R44 · FY2023 · NS
Core F: Biomarker Core$331,289
P30 · FY2023 · AG · contact PI
Precision Brain Health Monitoring for Alzheimer's Disease Risk Detection in the Framingham Study: Black & AA Recruitment Supplement$251,771
RF1 · FY2023 · AG
Lasting Impacts: Dynamic, Fully Natural Bioprinted 3D Human Neurovascular Biomimetic Model to Study Traumatic Brain Injury Pathophysiology$978,033
R61 · FY2022 · HL
TBI identification and monitoring through retinal scanning$517,500
R44 · FY2022 · NS
Precision Brain Health Monitoring for Alzheimer's Disease Risk Detection in the Framingham Study$346,463
RF1 · FY2022 · AG
Core F: Biomarker Core$331,419
P30 · FY2022 · AG · contact PI
Precision Brain Health Monitoring for Alzheimer's Disease Risk Detection in the Framingham Study$1,836,408
RF1 · FY2021 · AG
Lens β-Amyloid Biomarker for Early Detection of Preclinical Alzheimer's Disease in the Framingham Study$1,682,982
RF1 · FY2021 · AG · contact PI
Lasting Impacts: Dynamic, Fully Natural Bioprinted 3D Human Neurovascular Biomimetic Model to Study Traumatic Brain Injury Pathophysiology$981,821
R61 · FY2021 · HL
Big data and small molecules for Alzheimer's disease$412,500
RF1 · FY2021 · AG
Core F: Biomarker Core$376,295
P30 · FY2021 · AG · contact PI
Molecular and Cellular Pathways Regulating Neurovascular Dysfunction in Degenerative Tauopathies$827,748
R56 · FY2020 · AG · contact PI
Big data and small molecules for Alzheimer's disease$412,500
RF1 · FY2020 · AG
Big data and small molecules for Alzheimer's disease$2,035,223
RF1 · FY2019 · AG
ROLE OF ABETA-PROTEIN AND METAL INTERACTIONS IN ALZHEIMER?S DISEASE$9,232
P41 · FY2011 · RR · contact PI
Femtosecond Infrared Laser Ablation Platform$418,549
S10 · FY2010 · RR · contact PI
AD LENS PATHOLOGY: BIOCHEMISTRY & DIAGNOSTIC IMAGING$103,704
R01 · FY2010 · GM · contact PI
ROLE OF ABETA-ALPHAB CRYSTALLIN INTERACTIONS IN ALZHEIMER?S DISEASE$8,097
P41 · FY2010 · RR · contact PI
AD LENS PATHOLOGY: BIOCHEMISTRY & DIAGNOSTIC IMAGING$261,935
R01 · FY2009 · GM · contact PI
ROLE OF ABETA-ALPHAB CRYSTALLIN INTERACTIONS IN ALZHEIMER?S DISEASE$9,492
P41 · FY2009 · RR · contact PI
AD LENS PATHOLOGY: BIOCHEMISTRY & DIAGNOSTIC IMAGING$261,935
R01 · FY2008 · GM · contact PI
AD LENS PATHOLOGY: BIOCHEMISTRY & DIAGNOSTIC IMAGING$32,000
R01 · FY2008 · GM · contact PI
AD LENS PATHOLOGY: BIOCHEMISTRY & DIAGNOSTIC IMAGING$266,549
R01 · FY2007 · GM · contact PI
Alzheimer's Disease beta-Amyloid in the Lens$182,345
K23 · FY2007 · AG · contact PI
MAGNETIC SECTOR FIELD HIGH RESOLUTION INDUCTIVELY-COUPLED MASS SPECTROMETER$422,852
S10 · FY2006 · RR · contact PI
MAGNETIC SECTOR FIELD HIGH RESOLUTION MASS SPECTROMETER$422,852
S10 · FY2006 · RR · contact PI
AD LENS PATHOLOGY: BIOCHEMISTRY & DIAGNOSTIC IMAGING$274,908
R01 · FY2006 · GM · contact PI
Alzheimer's Disease beta-Amyloid in the Lens$175,640
K23 · FY2006 · AG · contact PI
MAGNETIC SECTOR FIELD HIGH RESOLUTION INDUCTIVELY-COUPLED MASS SPECTROMETER$1
S10 · FY2006 · RR · contact PI
AD LENS PATHOLOGY: BIOCHEMISTRY &DIAGNOSTIC IMAGING$281,044
R01 · FY2005 · GM
Alzheimer's Disease beta-Amyloid in the Lens$169,192
K23 · FY2005 · AG
Alzheimer's Disease beta-Amyloid in the Lens$204,823
K23 · FY2004 · AG
Alzheimer's Disease Beta-Amyloid in the Lens$40,646
K08 · FY2004 · AG
Alzheimer's Disease Beta-Amyloid in the Lens$162,000
K08 · FY2003 · AG